These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2475778)

  • 21. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
    Velanovich V
    Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
    Harris EE; Hwang WT; Lee EA; Cengel KA; Feldman MD; Demichele A; Kao G; Solin LJ
    Breast J; 2006; 12(5):431-6. PubMed ID: 16958961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
    Haffty BG; Hauser A; Choi DH; Parisot N; Rimm D; King B; Carter D
    Cancer; 2004 Jan; 100(2):252-63. PubMed ID: 14716758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is triple negative a prognostic factor in breast cancer?
    Nishimura R; Arima N
    Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status.
    Kuhajda FP; Eggleston JC
    Am J Pathol; 1985 Nov; 121(2):342-8. PubMed ID: 2414998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical detection of bcl-2 and MIB-1/Ki-67 in breast cancer: retrospective analysis of 238 cases].
    Sundlad AS; Ahn C; Battifora H
    Medicina (B Aires); 1996; 56(3):252-8. PubMed ID: 9035481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
    Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
    Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.
    Katoh A; Breier S; Stemmler N; Specht S; Blanock K; D'Amico F
    Anticancer Res; 1996; 16(3A):1301-4. PubMed ID: 8702254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
    Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
    BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Ivanov O; Chen F; Wiley EL; Keswani A; Diaz LK; Memmel HC; Rademaker A; Gradishar WJ; Morrow M; Khan SA; Cryns VL
    Breast Cancer Res Treat; 2008 Oct; 111(3):411-7. PubMed ID: 17968656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of haptoglobin-related protein in primary and metastatic breast cancers. A longitudinal study of 48 fatal tumors.
    Shurbaji MS; Pasternack GR; Kuhajda FP
    Am J Clin Pathol; 1991 Aug; 96(2):238-42. PubMed ID: 1862779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of haptoglobin-related protein and its potential role as a tumor antigen.
    Kuhajda FP; Katumuluwa AI; Pasternack GR
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1188-92. PubMed ID: 2465547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estrogen receptor and progesterone receptor as a prognostic indicator of breast cancer].
    Ikeda T; Enomoto K; Kubouchi K; Shimada M; Fujiwara K; Abe O
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):703-9. PubMed ID: 3404020
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum prolactin levels in women with breast cancer and their relationship to survival.
    Wang DY; Hampson S; Kwa HG; Moore JW; Bulbrook RD; Fentiman IS; Hayward JL; King RJ; Millis RR; Rubens RD
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):487-92. PubMed ID: 3732352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the human serum trypanosome toxin, haptoglobin-related protein.
    Muranjan M; Nussenzweig V; Tomlinson S
    J Biol Chem; 1998 Feb; 273(7):3884-7. PubMed ID: 9461571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular expression of epitopes recognized by monoclonal antibodies HMFG-1 and HMFG-2 in human breast cancers: diversity, variability and relationship to prognostic factors.
    Turnbull JE; Baildam AD; Barnes DM; Howell A
    Int J Cancer; 1986 Jul; 38(1):89-96. PubMed ID: 2424847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.